EXHIBIT 99.2

Q1 2006 Preliminary Consolidated Financial Results

(in millions, except per share amounts)

	Range for Q1 2006
Revenue	$	338.0	$	339.0
Adjusted EBITDA per diluted share	$	0.18	$	0.18
Reconciliation of Adjusted EBITDA per diluted share to Net Income per diluted share:
Interest expense	$	—	$	—
Depreciation and amortization		0.06		0.06
Non-cash stock-based compensation		0.04		0.04
Non-cash advertising		0.01		0.01
Income tax provision		0.02		0.01
Minority interest in WebMD Health Corp.		—		—
Net income per diluted share	$	0.05	$	0.06

2006 Consolidated Financial Guidance Summary

(in millions, except per share amounts)

	Range for FY 2006
Revenue	$	1,380.0		$	1,430.0
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”)	$	225.0		$	255.0
Reconciliation of Adjusted EBITDA per diluted share to Net Income per diluted share:
Interest expense	$	3.0		$	4.0
Depreciation and amortization		75.5			80.1
Non-cash stock-based compensation		48.0			50.0
Non-cash advertising		7.3			7.5
Income tax provision		21.0			22.6
Legal expense		0.5			0.5
Minority interest in WebMD Health Corp.		(0.3	)		0.3
Net income	$	70.0		$	90.0
Adjusted EBITDA per diluted share	$	0.75		$	0.85
Net income per diluted share	$	0.23		$	0.30

Notes:

*	The 2006 guidance includes estimated expenses for Q1 2006, but does not reflect any projected expenses related to the on-going Department of Justice Investigation.
*	Adjusted EBITDA per diluted share and net income per diluted share are both calculated on an assumed share count of approximately 299 million.
*	Non-cash stock-based compensation expense considers the January 1, 2006 adoption of SFAS 123R, “Share-Based Payment.”
*	The 2006 Guidance does not include the impact of the acquisition of Summex Corp. announced by WebMD Health on Monday, April 17, 2006.